The Managing Director Founder of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), one of the Best Biotech Stocks, Leonard Bell has contacted the Board OF Directors making known his intentions to refrain from standing on the coming re-election as a board member. He stated it clearly that he would be happy to retire as Director and Chairman of the board.
The boards couldn’t dispute the top official’s decision but it was happy about the long term he had offered his services to the company. Anyway, things had to continue as usual and thus there needed someone to fill the void left by the outgoing chairman.
The board has made up its mind to settle for Alexion’s Interim Chief Executive Officer and fellow Board member, David Brennan to take over to assist the company forge forward in terms of development.
Alexion’s Lead Independent Director, R. Douglas Norby, on behalf of the leading company extended deep appreciation to Leonard Bell, terming his decision as a great show of selflessness. The leader during his tenure of office had a clear vision as well as extra ordinary abilities which had helped propel the company to the position it boats of today.
He termed Lenny as an “extra ordinary giant” in the area of biotechnology and also in a great way appreciated the efforts of the outgoing leader towards assisting the company embrace the new era of modern medicine.
He always showcased unwavering dedication and perseverance which took the company’s research to a completely new level. The very fact that Alexion has emerged to become a global biopharmaceutical leader has much to do with the way he conducted himself while serving in the capacity of the Company CEO.
His resignation comes as an end o a great era and it is time the company re-focused and embraced the new CEO. He would need support from the board members and other concerned parties in order to fit in the shoes of the out-going leader as well as propel the company towards economic gain and also stand out as one of the Top Biotech Stocks.